BackLiminal Biosciences Overview

Liminal Biosciences Research & Development

Research & Development expenses for LMNL.

Quarterly R&D Expenses

$4.34M
↑ 10.07% YoY

As of Jun 30, 2023

Annual R&D Expenses (TTM)

$15.49M
↓ 13.12% YoY

Trailing 12 months ending Jun 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin